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Abstract
Co-infection of tuberculosis (TB)-HIV/AIDS is a persistent public health 
problem in Brazil. This study describes epidemiological patterns and time 
trends of mortality related to TB-HIV/AIDS co-infection. Based on mortal-
ity data from 2000-2011 (almost 12.5 million deaths), 19,815 deaths re-
lated to co-infection were analyzed. The average age-adjusted mortality 
rate was 0.97 deaths/100,000 inhabitants. The highest mortality rates were 
found among males, those in economically productive age groups, black 
race/color and residents of the South region. There was a significant re-
duction in the mortality coefficient at the national level (annual average 
percent change: -1.7%; 95%CI: -2.4; -1.0), with different patterns among 
regions: increases in the North, Northeast and Central regions, a reduction 
in the Southeast and a stabilization in the South. The strategic integration 
of TB-HIV/AIDS control programmes is fundamental to reduce the burden 
of mortality related to co-infection in Brazil.
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Introduction
HIV/AIDS is an important and persistent pub-
lic health problem in Brazil and worldwide, with 
a high morbidity and mortality burden, mainly 
when related to opportunistic infections such 
as tuberculosis (TB) 1,2. People living with HIV/
AIDS are 21-34 times more likely to develop ac-
tive TB as compared to the general population 3. 
Active TB in people living with HIV/AIDS is a sig-
nificant risk factor to increased HIV/AIDS and 
TB-related case fatality rates. People living with 
HIV/AIDS with TB are twice more likely to prog-
ress to death, in comparison with people living 
with HIV/AIDS without TB 4,5.
In 2012, approximately 8.7 million individu-
als developed TB worldwide, 1.1 million (13%) 
of them living with HIV/AIDS 4,5. On the other 
hand, about 20% of the 2.8 million people diag-
nosed with TB and tested for HIV had a positive 
HIV status. In this group, 42% were living in Sub-
Saharan Africa. More than 75% of new cases of 
TB in HIV-positive patients are concentrated in 
10 countries 4,5.
According to the Joint United Nations Pro-
gramme on HIV/AIDS (UNAIDS), the global goal 
is to reduce by half the number of deaths due to 
TB among people living with HIV/AIDS world-
wide (to less than 250,000) 4,5. In fact, about 1.3 
million individuals benefitted from the integra-
tion of TB and HIV/AIDS control programs, and 
did not progress to death between 2005 and 2012. 
In 17 of the 41 countries with a high number of 
co-infected patients with TB and HIV/AIDS, 
mortality declined by 50% or more. On the other 
hand, mortality decreased by less than 25% in 
Brazil during this period 4,5,6.
In Brazil, TB-HIV/AIDS co-infection presents 
a heterogeneous distribution among population 
groups 6. The occurrence of TB-HIV/AIDS co-in-
fection ranged among Brazilian states, from 2.2% 
in Acre State in the North region to 19.3% in Rio 
Grande do Sul State in the South region 6,7,8.There 
has been a continuous decrease of nationwide 
mortality related to HIV/AIDS (by 6.6% in the 
period 2004-2013) 9, and TB (by 2.9% in the pe-
riod 2001-2010) 6,10. In 2013, 59.2% of new cases 
diagnosed with TB performed and received the 
results of HIV testing, with 9.8% TB-HIV/AIDS 
co-infections 6.
Despite the clinical, epidemiological and so-
cial relevance of TB-HIV/AIDS co-infection in 
Brazil, there are few systematic studies of nation-
al or regional scale on the epidemiological as-
pects and temporal evolution of mortality related 
to this co-infection in the country 6,9. Knowledge 
of the impact of mortality related to TB-HIV/
AIDS co-infection is important to assess endemic 
dynamics, and to improve surveillance and con-
trol activities 9,10. In this nationwide study, we 
analyzed the epidemiological patterns and time 
trends of mortality related to TB-HIV/AIDS co-
infection in Brazil, from 2000 to 2011.
Material and methods
Study area
Brazil has a total area of 8.5 million km2 and, in 
2015, had an estimated population of 204,5 mil-
lion inhabitants (in the study period, ranging from 
170 million in 2000 to 192.4 million inhabitants 
in 2011). The country is divided into five admin-
istrative geographic regions (South, Southeast, 
Central, North and Northeast), 27 Federal Units 
(26 states and one Federal District), and 5,570 
municipalities (Brazilian Institute of Geography 
and Statistics – IBGE; http://www.ibge.gov.br). 
There are considerable economic, geographical 
and cultural diversities in each Brazilian region.
Study design and population
We performed a nationwide population-based 
study in Brazil using official secondary mortality 
data. We included all deaths related to TB-HIV/
AIDS co-infection recorded in Brazil in the period 
from 2000 to 2011. Co-infection was defined as 
the concomitant presence of TB and HIV/AIDS 
on the same death certificate, either as under-
lying or as associated causes of death: multiple 
causes of death 11.
Tuberculosis as cause of death corresponds 
to the categories included in the group A15-A19 
(Tuberculosis), while HIV/AIDS corresponds to 
the group B20-B24 (Human immunodeficiency 
virus [HIV] disease) of the 10th revision of the In-
ternational Statistical Classification of Diseases 
and Related Health Problems (ICD-10) 12.
Data sources
Mortality data were obtained from the Mortality 
Information System (SIM) of the Brazilian Minis-
try of Health. SIM data are available at the web-
site of the Informatics Department of the Brazil-
ian Unified National Health System (DATASUS; 
http://datasus.saude.gov.br). All information in 
the SIM database is based on death certificates, 
consisting of a standardized form to be filled out 
by physicians, which contains demographic (sex, 
age, race/color, marital status, education, place 
of residence and year of occurrence of death), 
and clinical information (underlying and associ-
ated causes of death).
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In the SIM database, data sets are separated 
by Federal Unit and year of death. Thus, a total 
of 324 data files (27 Federal Units, 12 years) with 
approximately 12.5 million entries were down-
loaded and merged into a single data file. In a 
second stage, field codes of different data sets 
were standardized, and we eliminated variables 
not considered in the analysis. All death certifi-
cates related to TB and HIV/AIDS as a cause of 
death in any field were identified. New variables 
for death causes were coded, as in many cases 
there was more than one documented cause of 
death per line.
Population data were obtained from the 
IBGE, based on data from the National Demo-
graphic Censuses (2000 and 2010), and popula-
tion estimates for inter-census years (2001-2009 
and 2011). These population data are available in 
the DATASUS (http://tabnet.datasus.gov.br/cgi/
deftohtm.exe?ibge/cnv/popuf.def).
Data analysis
For the descriptive analysis, we present the mean 
and standard deviation (SD) for continuous vari-
ables, and absolute numbers and proportions 
with their respective 95% confidence intervals 
(95%CI) for categorical variables.
We calculated crude mortality rates (per 
100,000 inhabitants) by sex, age group, race/col-
or and place of residence (states and regions) by 
dividing the number of deaths by the population 
in each calendar year, and expressed per 100,000 
inhabitants. We calculated age-adjusted mortal-
ity rates by the direct method, using as standard 
the Brazilian population from the 2010 census. 
The age groups used for standardization and cal-
culation of age-specific mortality rates were: 0-4, 
5-9, 10-19, 20-29, 30-39, 40-49, 50-59, 60-69 and 
≥ 70 years. Then, based on the values of crude 
mortality rates, we calculated the rate ratios (RR) 
and the respective 95%CI to determine the differ-
ences between the study groups (sex, age group, 
race/color and regions).
Trend analyses of mortality rates were per-
formed using joinpoint regression models 13. This 
analysis uses an algorithm which tests whether a 
multi-segmental line is significantly better than 
a straight line or a line with fewer segments. The 
analysis started with a minimum number of join-
points (for example, 0 joinpoints, resulting in a 
straight line) and tested if one or more joinpoints 
(in our analysis up to 3 joinpoints) increased the 
significance when added to the model. Each join-
point indicates a statistically significant change 
in the slope. Statistical significance was tested 
using the Monte Carlo permutation test, which 
chooses the best segment for each model. The 
annual percent change (APC) and 95%CI was cal-
culated for each segment. To simplify trend com-
parison for the indicators with more than one 
slope, we also calculated the average annual per-
cent change (AAPC) over the entire period. The 
AAPC was estimated as the geometric-weighted 
mean of the APC, with weights equal to the length 
of each time interval segment. Trends were con-
sidered statistically significant when APC and 
AAPC presented a p-value < 0.05 13.
Data analysis was performed using the Stata 
software package, version 11.2 (StataCorp LP, 
College Station, USA). Joinpoint regression anal-
ysis was performed using the Regression Join-
point Program version 4.0.4 (US National Cancer 
Institute, Bethesda, USA). We created thematic 
maps of spatial distribution of mortality rates by 
state of residence using ArcGIS software version 
9.3 (Environmental Systems Research Institute, 
Redlands, USA).
Ethical aspects
SIM and IBGE databases are available in a public 
domain and do not allow identification of indi-
viduals. This study was approved by the Ethical 
Review Board of the Federal University of Ceará, 
Fortaleza, Ceará State, Brazil, under protocol 
number 699,138/2014.
Results
In the period from 2000 to 2011, a total of 
12,491,280 deaths were recorded in Brazil, with 
92,144 (0.74%) TB-related deaths and 144,175 
(1.2%) HIV/AIDS-related deaths. We identified a 
total of 19,815 deaths in which TB and HIV/AIDS 
were mentioned on the same death certificates 
(21.5% of deaths by TB and 13.7% of deaths by 
HIV/AIDS). HIV/AIDS was mentioned as un-
derlying cause in 98.6% (19,541/19,815) of these 
deaths, and TB in 0.03% (6/19,815). The average 
annual crude and age-adjusted mortality rate 
was 0.89 deaths/100,000 inhabitants and 0.97 
deaths/100,000 inhabitants, respectively.
Epidemiological characteristics
The predominating socio-demographic char-
acteristics were: male sex (70.2%), white race/
color (48.2%), single marital status (72.4%), age 
30-39 years (38.1%, mean: 38.9; SD ± 10.5; me-
dian: 38.1), and residence in the Southeast region 
(53.5%) (Table 1). São Paulo State (Southeast re-
gion) presented about one third of all deaths re-
lated to co-infection (30.5%) (Table 1). Although 
about half did not reside in state capitals (54.9%), 
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Table 1
Epidemiological characteristics of deaths related to TB-HIV/AIDS co-infection in Brazil, 2000-2011 (n = 19,815).
Characteristics n %
Sex *
Male 13,905 70.17
Female 5,906 29.81
Age group (years) *
0-4 45 0.23
5-9 35 0.18
10-19 212 1.08
20-29 3,464 17.64
30-39 7,483 38.11
40-49 5,660 28.82
50-59 2,049 10.43
60-69 551 2.81
≥ 70 137 0.70
Race/Color *
White 8,944 48.24
Brown 6,261 33.77
Black 3,233 17.44
Yellow 71 0.38
Indigenous 30 0.16
Marital status *
Single 13,266 72.45
Married 3,154 17.22
Divorced/Separated 865 4.72
Widow 809 4.42
Stable partner 216 1.18
Education level (years) *
None 885 7.02
1-3 3,339 26.48
4-7 5,207 41.30
8-11 2,401 19.04
≥ 12 776 6.15
Region of residence
Southeast 10,596 53.47
South 4,975 25.11
Northeast 2,661 13.43
North 847 4.27
Central 736 3.71
State of residence
São Paulo (Southeast) 6,042 30.49
Rio Grande do Sul (South) 3,333 16.82
Rio de Janeiro (Southeast) 3,293 16.62
Minas Gerais (Southeast) 987 4.98
Pernambuco (Northeast) 850 4.29
Other Brazilian states 5,310 26.80
Residence in state capital
Yes 8,924 45.03
No 10,891 54.96
Occurrence in state capital
Yes 11,753 59.31
No 8,062 40.68
Place of occurrence *
Hospital 18,505 93.44
Other health services 456 2.30
Residence 644 3.25
Public areas 32 0.16
Other 166 0.83
* Data not available in all cases (sex: 4, age group: 179, race/color: 1,276, marital status: 1,505, education level: 7,207; place 
of occurrence: 12).
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the place of occurrence of deaths was almost ex-
clusively in urban hospitals (93.4%) and in the 
Brazilian state capitals (59.3%) (Table 1).
The age-adjusted mortality rates were 
higher among males than females (1.37 vs. 0.55 
deaths/100,000 inhabitants, respectively), with a 
RR of 2.43 (95%CI: 2.18; 2.70) (Table 2). The mor-
tality rates was higher in the age groups 30-39 and 
40-49 years. The black population had a 2.6-fold 
greater risk as compared to the white population, 
while brown race/color showed lower mortality 
rates compared to white race/color (Table 2). The 
South and Southeast regions showed the high-
est mortality rates (1.55 and 1.12 deaths/100,000 
inhabitants, respectively), with significant differ-
ences when compared to the North region (Table 
2). The highest average annual mortality rates by 
state of residence were observed in Rio Grande 
do Sul (South region) (2.55 deaths/100,000 in-
habitants), followed by the states of Rio de Ja-
neiro (1.77 deaths/100,000 inhabitants) and São 
Paulo (1.24 deaths/100,000 inhabitants), both in 
the Southeast region (Figure 1).
Temporal trends
We observed a significant decreasing trend of 
age-adjusted mortality rates at national level 
(AAPC: -1.7%; 95%CI: -2.4; -1.0), with consider-
able regional variations (Figure 2; Table 3). Mor-
Table 2
Average annual mortality rates related to TB-HIV/AIDS co-infection (per 100,000 inhabitants) stratified by sex, age group, race/color and region of residence. 
Brazil, 2000-2011.
Variables Crude mortality rate (per 
100,000 inhabitants) *
Age-adjusted mortality rate (per 
100,000 inhabitants) *, **
RR 95%CI p-value
Sex
Male 1.29 1.37 2.43 2.18; 2.70 < 0.001
Female 0.53 0.55 - - -
Age groups (years)
0-4 0.02 - - - -
5-9 0.02 - 0.77 0.17; 3.57 NS
10-19 0.04 - 2.20 0.72; 6.70 NS
20-29 0.88 - 42.06 15.19; 116.47 < 0.001
30-39 2.28 - 107.87 39.09; 297.71 < 0.001
40-49 2.16 - 107.45 38.9; 296.83 < 0.001
50-59 1.13 - 60.22 21.65; 167.54 < 0.001
60-69 0.48 - 24.87 8.68; 71.27 < 0.001
≥ 70 0.15 - 7.99 2.49; 25.65 < 0.001
Region of residence
North 0.47 0.58 - - -
Northeast 0.43 0.52 0.91 0.70; 1.19 NS
Southeast 1.12 1.12 2.35 1.85; 3.00 < 0.001
South 1.53 1.55 3.22 2.50; 4.14 < 0.001
Central 0.47 0.48 0.98 0.70; 1.38 NS
Race/Color
White 0.82 - - - -
Black 2.15 - 2.63 2.29; 3.02 < 0.001
Yellow 0.42 - 0.51 0.23; 1.14 NS
Brown 0.70 - 0.87 0,77; 0.97 0.011
Indigenous 0.32 - 0.39 0.11; 1.36 NS
95%CI: 95% confidence interval; NS: not significant; RR: rate ratio. 
* Average annual mortality rates were calculated using the average number of deaths related to TB-HIV/AIDS co-infection as a numerator and population size 
in the middle of the period as a denominator. Population data on race/color derived from the National Census (2000 and 2010). Population size of individuals 
by race/color in the period was calculated as the average of the population by race/color in the 2000 and 2010 censuses; 
** Age-standardized mortality rates (by the Brazilian population of 2010 Census).
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tality increased significantly in the North (AAPC: 
5.7%; 95%CI: 2.2; 9.4), Northeast (AAPC: 5.4%; 
95%CI: 3.3; 7.6), and Central (AAPC: 3.5%; 95%CI: 
0.2; 6.9) regions. In contrast, we observed a de-
creasing trend in the Southeast region over the 
entire period (AAPC: -4.1%; 95%CI: -2.4; -1.0), 
with a decrease in the period 2000-2005 and a 
stabilization in the period 2005-2011. The South 
region presented a stable trend in the period 
(AAPC: -0.5%; 95%CI: -2.9; -1.9), with an increase 
from 2000 to 2004, and a decrease trend in the 
period 2004-2011 (Table 3).
The sex-specific mortality rate presented a 
significant decreasing trend for males and a sta-
ble trend for females (Table 3). For age-specific 
rmortality ates, we observed a significant de-
crease in the 20-29 year-old and 30-39 year-old 
age groups. The older age groups showed signifi-
cant increasing trends of mortality rates: 50-59 
year-olds, 60-69 year-olds and ≥ 70 year-olds. The 
mortality in pediatric and younger age groups, 
and in 40-49 year-olds remained stable during 
the study period (Table 3).
Discussion
In this nationwide population-based study, pre-
sented a comprehensive overview of magnitude 
and time trends of mortality related to TB-HIV/
Figure 1
Spatial distribution of average annual mortality rates related to TB-HIV/AIDS co-infection (per 100,000 inhabitants) by states of 
residence. Brazil, 2000-2011.
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Figure 2
Trends of age-adjusted mortality rates related to TB-HIV/AIDS co-infection (per 100,000 inhabitants) in Brazil and regions, 
2000-2011.
AIDS co-infection in Brazil over a 12-year period. 
Our data show a decreasing trend of mortality in 
Brazil, but with different patterns among regions, 
with increasing trends in the poorest regions of 
the country, such as the North and Northeast 
regions. There was a higher mortality burden 
among males, individuals of a working age, those 
of black race/color and residents in high HIV/
AIDS-endemic states/regions 3,4,5,14.
The South and Southeast regions (including 
the states of Rio Grande do Sul, São Paulo and 
Rio de Janeiro) had the highest mortality rates 
related to TB-HIV/AIDS co-infection 15, but with 
a continuous decreasing trend in recent years. 
These results probably reflect the introduction 
and spread of the AIDS epidemic in the country. 
The state of São Paulo presented the first cases 
of the epidemic, followed by the state of Rio de 
Janeiro. These states significantly contributed to 
a rapid growth in the number of AIDS cases in 
the country 16.
We emphasize that the North and North-
east regions, the poorest regions of the country, 
showed increasing mortality rates in the study 
period 17. Our results reinforce the ongoing 
change of transmission dynamics of HIV/AIDS 
infection, from socio-economically well-off 
population groups in urban centers, to more 
socio-economically deprived vulnerable popu-
lations in rural areas, with a consequent in-
creased risk for concomitant TB infection. Our 
data confirm previous studies indicating tremen-
dous social inequalities being a major risk for 
co-infection 17,18.
The distribution of mortality rates according 
to demographic characteristics portrays a con-
tinuous decreasing trend for males and working 
age populations (20-49 years) 18. This trend has 
been observed in infections caused by TB and 
HIV/AIDS and similarly overall infection rates 
can be linked to transmission dynamics, consid-
ering socio-economic, environmental and be-
havioral factors 19. Our data also show a signifi-
cant increase of mortality related to co-infection 
in the elderly. Two different patterns were iden-
tified: those infected < 60 years-old with better 
survival rates due to improved antiretroviral ther-
apy (ART), including highly active antiretroviral 
therapy (HAART), and those infected > 60 years-
old. The high vulnerability in these population 
groups increases the risk of developing both dis-
eases as a result of higher previous exposure rates 
to Mycobacterium tuberculosis. Other factors in 
the elderly include the increased likelihood of 
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atypical presentations of TB, comorbidity, resis-
tance to condom use and delayed detection of 
HIV infection 20,21.
We have observed a decrease in deaths 
among children < 10 years. In fact, TB incidence 
has been reduced in this age group in recent de-
cades 6,10. BCG vaccination coverage is also very 
high in Brazil (reaching 100% in recent years) re-
sulting in enhanced protection against invasive 
forms of childhood TB 20. In addition, mother-
to-child transmission of HIV has been reduced 
effectively in Brazil as a result of integrated con-
trol programs 16,22. There has been an increased 
access to prenatal care services and assisted birth 
in HIV-positive mothers, including antiretrovi-
ral medication in HIV infected pregnant women 
and exposed newborns 22. There was estimated 
to occur a 78% reduction in mother-to-child 
transmission of HIV between 2001 and 2013 in 
Latin America and the Caribbean. Of the total of 
women who gave birth in 2013 (11 million), 87% 
had at least four prenatal consultations number 
(the recommended minimum), 74% had access 
to HIV testing and counseling, and 93% of HIV-
positive pregnant women received HAART (34% 
increase compared to 2010) 22,23,24.
Some strategies have favored an improve-
ment in mortality indicators related to TB-HIV/
AIDS co-infection. These strategies include: free 
dispensing of antiretroviral drugs for treatment 
of AIDS since 1996, continuous updating of clini-
cal protocols and therapeutic guidelines for the 
management of HIV infection in adults (2014), 
children and adolescents (2014), and prophylaxis 
of vertical transmission of HIV and antiretrovi-
ral therapy in pregnant women (2010) 9,16,22,25. In 
2014, HIV infection was included in the Brazilian 
list of notifiable diseases, further aiming at im-
proving disease control 9.
Our data show regional differences, which 
may reflect operational factors in the implemen-
tation of these measures. Mortality rates were 
higher in regions considered as more economi-
cally developed, with increasing trends in other 
regions, consistent with the AIDS expansion pro-
cess in Brazil. The presence of variables consid-
Table 3
Joinpoint regression analysis of mortality rates related to TB-HIV/AIDS co-infection by region, sex and age group.  
Brazil, 2000-2011.
Variables Trend 1 Trend 2 Entire period
Period APC 95%CI Period APC 95%CI AAPC 95%CI
Region
North 2000-2011 5.7 * 2.2; 9.4 - - - 5.7 * 2.2; 9.4
Northeast 2000-2011 5.4 * 3.3; 7.6 - - - 5.4 * 3.3; 7.6
Southeast 2000-2005 -8.5 * -10.7; -6.2 2005-2011 -1.9 -3.9; 0.2 -4.1 * -5.4; -2.8
South 2000-2004 10.7 * 2.3; 19.9 2004-2011 -3.5 * -6.3; -0.6 -0.5 -2.9; 1.9
Central 2000-2011 3.5 * 0.2; 6.9 - - - 3.5 * 0.2; 6.9
Brazil 2000-2011 -1.7 * -2.4; -1.0 -1.7 * -2.4; -1.0
Sex
Female 2000-2011 -0.1 -1.2; 0.9 - - - -0.1 -1.2; 0.9
Male 2000-2011 -2.4 * -3.1; -1.6 - - - -2.4 * -3.1; -1.6
Age group (years)
0-4 2000-2011 -8.0 -15.9; 0.6 - - - -8.0 -15.9; 0.6
5-9 2000-2011 -4.3 -11.1;  3.0 - - - -4.3 -11.1; 3.0
10-19 2000-2011 2.4 -1.8; 6.7 - - - 2.4 -1.8; 6.7
20-29 2000-2006 -7.8 * -9.8; -5.6 2006-2011 0.1 -3.1; 3.4 -4.3 * -5.8; -2.7
30-39 2000-2011 -3.2 * -4.1; -2.4 - - - -3.2 * -4.1; -2.4
40-49 2000-2011 -0.4 -1.3; 0.5 - - - -0.4 -1.3; 0.5
50-59 2000-2011 2.4 * 0.6; 4.2 - - - 2.4 * 0.6; 4.2
60-69 2000-2011 3.4 * 0.7; 6.2 - - - 3.4 * 0.7; 6.2
≥ 70 2000-2011 3.8 * 0.4; 7.4 - - - 3.8 * 0.4; 7.4
95%CI: 95% confidence interval; AAPC: average annual percent change; APC: annual percent change. 
* Significantly different from 0 (p < 0.05).
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ered indicators for poverty in Brazil and a higher 
risk among those with a low education and the 
black population, confirms the increased mortal-
ity in these regions 6,9,10,15,16,26,27.
Similar to other infectious diseases, poverty 
may have increased the vulnerability for TB and 
HIV/AIDS cases. There is a clear link between 
TB, poverty and social exclusion, hampering 
control efforts in many Brazilian regions 10,27,28. 
Those who are mostly affected live in poor, urban 
neighborhoods, with a trend to more and more 
rural areas 9. HIV/AIDS is being spread within the 
poorest populations in the country, with negative 
impacts on clinical and epidemiological aspects 
22,27. In cases with TB-HIV/AIDS co-infection, 
poverty has previously been shown to be related 
to higher mortality rates 10,26,29.
Reduced access to information, insufficient 
knowledge, and reduced access to health care 
may result in a delay of diagnosis, late treatment 
and low adherence to treatment 18,23. The current 
challenge is to integrate TB and AIDS control pro-
grams effectively 10,30. The contrast of the reduc-
tion of mortality in the South region and the in-
crease of mortality rates in the North, Northeast 
and Central regions reflects socio-economic dif-
ferences between these regions. Regional dispar-
ities and social determinants directly reflected in 
different patterns of the quality of health care and 
information systems 10,28.
Our study is subject to limitations. The use 
of secondary data may have limited the analy-
sis, as many variables of interest are not available 
with under registering of deaths. On the other 
hand, we assume that the databases are of ac-
ceptable quality, considering the improvement 
of coverage and quality of SIM records during 
recent years 9,16,31. However, there still may ex-
ist regional differences in the performance and 
quality of data, and the number of deaths related 
to TB-HIV/AIDS co-infections may have been 
underestimated 31, especially in the North and 
Northeast regions. There were a considerable 
number of data sets with missing information, 
especially for race/color, education and marriage 
status, thus the respective analyses and interpre-
tation should be performed with caution 32,33,34. 
Despite these limitations, the results of this study 
are highly representative, as all death certificates 
recorded in Brazil have been included, during a 
period of 12 years (2000-2011) 34,35.
In conclusion, our study shows a consistent 
decline of the mortality related to TB-HIV/AIDS 
co-infection in Brazil, despite the high levels still 
observed. Population groups at high risk have 
been identified, with consistent regional dif-
ferences. The increasing mortality trend in the 
socio-economically most disadvantaged North, 
Northeast and Central regions is worrying. We 
recognize the need for implementation and 
monitoring the control actions for TB/HIV co-
infection to reduce the morbidity and mortality 
burden in all Brazilian regions.
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Resumo
A coinfecção tuberculose (TB)-HIV/AIDS é um proble-
ma de saúde pública persistente no Brasil. Neste estu-
do, descrevem-se padrões epidemiológicos e tendências 
temporais da mortalidade relacionada à coinfecção 
TB-HIV/AIDS. Baseado em dados de mortalidade de 
2000-2011 (quase 12,5 milhões de mortes), foram ana-
lisados 19.815 óbitos relacionados à coinfecção. O coe-
ficiente médio de mortalidade padronizado por idade 
foi de 0,97 óbitos/100 mil habitantes. Os maiores coefi-
cientes de mortalidade foram verificados no sexo mas-
culino, grupos etários economicamente produtivos, 
raça/cor negra e residentes da Região Sul. Houve dimi-
nuição significativa dos coeficientes de mortalidade 
em nível nacional (variação percentual anual média: 
-1,7%; IC95%: -2,4; -1,0), com diferentes padrões entre 
regiões: aumento nas regiões Norte, Nordeste e Cen-
tro-oeste, redução na Sudeste e estabilização na Sul. 
A integração estratégica dos programas de controle de 
TB-HIV/AIDS é fundamental para reduzir a carga de 
mortalidade relacionada à coinfecção no Brasil.
Tuberculose; HIV; Síndrome de Imunodeficiência  
Adquirida; Estudos de Séries Temporais
Resumen
La coinfección tuberculosis (TB)-VIH/SIDA es un pro-
blema de salud pública persistente en Brasil. En este 
estudio, se describen patrones epidemiológicos y ten-
dencias temporales de la mortalidad relacionada con 
la coinfección TB-VIH/SIDA. Basado en datos de mor-
talidad de 2000-2011 (casi 12,5 millones de muertes), 
fueron analizadas 19.815 muertes, todas relacionadas 
con la coinfección. El coeficiente medio de mortalidad 
ajustado por edad fue de 0,97 muertes/100.000 habi-
tantes. Los mayores coeficientes se verificaron en el 
sexo masculino, grupos de edad económicamente pro-
ductivos, raza negra y residentes de la región Sur. Hubo 
una disminución significativa del coeficiente de mor-
talidad a nivel nacional (variación porcentual anual 
media: -1,7%; IC95%: -2,4; -1,0), con diferentes pa-
trones entre regiones: aumento en las regiones Norte, 
Nordeste y Centro-oeste, reducción en el Sudeste y es-
tabilización en el Sur. La integración estratégica de los 
programas de control de TB-VIH/SIDA es fundamental 
para reducir la carga de mortalidad, relacionada con 
la coinfección en Brasil.
Tuberculosis; VIH; Síndrome de Inmunodeficiencia 
Adquirida; Estudios de Series Temporales
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